Keyword

SelectMDx

Description: SelectMDx is a urinary biomarker test used to estimate the risk of clinically significant prostate cancer and inform biopsy decisions.
OpenAlex ID: keywords/selectmdx
2017 · Vito Cucchiara, Matthew R. Cooperberg, et al. · European Urology · 286
2019 · Indu Kohaar, Gyorgy Petrovics, et al. · International Journal of Molecular Sciences · 174
2016 · R J Hendriks, I M van Oort, et al. · Prostate Cancer and Prostatic Diseases · 151
2022 · Mark W. Farha, Simpa S. Salami · Therapeutic Advances in Urology · 121
2019 · Daniël F. Osses, Monique J. Roobol, et al. · International Journal of Molecular Sciences · 111
2021 · Milena Matuszczak, Jack A. Schalken, et al. · Cancers · 82
2017 · Rianne J. Hendriks, Marloes M. G. van der Leest, et al. · The Prostate · 79
2018 · Tim M. Govers, Daphne Hessels, et al. · Prostate Cancer and Prostatic Diseases · 71
2025 · Felice Crocetto, Michele Musone, et al. · The Journal of Liquid Biopsy · 62
2020 · Alex Uhr, Lydia Glick, et al. · PubMed · 61
2021 · Nicholas W. Eyrich, Todd M. Morgan, et al. · Translational Andrology and Urology · 60
2020 · Maria F. Becerra, Venkatasai S. Atluri, et al. · Urologic Oncology Seminars and Original Investigations · 57
2018 · Niranjan J. Sathianathen, Karen M. Kuntz, et al. · The Journal of Urology · 52
2024 · Yutong Liu, Koji Hatano, et al. · The World Journal of Men s Health · 35
2024 · Praise Agbetuyi-Tayo, Mary Gbadebo, et al. · Technology in Cancer Research & Treatment · 32
2017 · Sigrid V. Carlsson, Monique J. Roobol · Current Opinion in Urology · 32
2020 · Stephan Brönimann, Benjamin Pradere, et al. · Expert Review of Molecular Diagnostics · 31
2024 · Hunter S. Robinson, Sangmyung S. Lee, et al. · Prostate Cancer and Prostatic Diseases · 30
Works count: 126
Citation count: 2,316
Year
Topic
Type